In the 1861, French physician Paul Broca described a patient with a lesion to the left frontal lobe and marked inability to produce speech,1 but intact understa
In this study,1 the authors have combined institutional data from 5 centers to create a large series of patients receiving anterior column realignment (ACR) sur
The authors report a retrospective review of 80 initial cases of intracranial germ cell tumors (GCTs).1 They highlight 3 important findings. First, they found t
In “A comparison of minimally invasive and open transforaminal lumbar interbody fusion for Grade 1 degenerative lumbar spondylolisthesis: an analysis of the pro
Pituitary adenomas are common, benign, and the majority are asymptomatic.1 Approximately 10% of healthy individuals carry an asymptomatic pituitary adenoma that
Clinical decisions for the care of patients with poor grade subarachnoid hemorrhage (SAH) (World Federation of Neurosurgical Societies (WFNS) Score > 4) are
Of all patients suffering from stage IV melanoma, 40% to 50% will see their median overall survival reduced to 7 to 9 mo as a result of developing melanoma brai
The setting of a randomized trial can determine whether its findings are generalizable and can therefore apply to different settings. The contribution of low- and middle-income countries (LMICs) to neurosurgical randomized trials has not been systematically described before.
When the fourth edition of the Brain Trauma Foundation's Guidelines for the Management of Severe Traumatic Brain Injury were finalized in late 2016, it was known that the results of the RESCUEicp (Trial of Decompressive Craniectomy for Traumatic Intracranial Hypertension) randomized controlled trial of decompressive craniectomy would be public after the guidelines were released...
